Every month on GLP-1 therapy should include deliberate lifestyle investment
3rd GLP-1 Based Therapeutics Summit 2026 14th April 2026 - April 16, 2026 The 3rd GLP-1 Based Therapeutics Summit is the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations, mastering tolerability, drug delivery, and seizing the multi-billion dollar opportunity in non-obesity indications
There is a huge gap between the reported incidence of side-effects in the medical literature most of the studies sponsored by the drug manufactures and the apparent prevalence in the general population
Otherwise, dispose via our in-store recycling program
Because your doctor works for your insurance company , getting an "off-formulary" (not on your plan's approved drug list) medication like Wegovy is harder than with other insurers
When combining GLP-1 receptor agonists with insulin or sulfonylureas, the chance of experiencing hypoglycemia (low blood sugar) goes up